PBS should fund drug to treat breast cancer, endometriosis and gender dysphoria, experts recommend
Triptorelin, already listed for prostate cancer, should have unrestricted use, the Pharmaceutical Benefits Advisory Committee says Get our breaking news email , free app or daily news podcast The federal government should fund treatment for thousands of women with breast cancer or endometriosis, and children with gender dysphoria, according to the Pharmaceutical Benefits Scheme’s advisory…
We haven't written up this one. The Guardian Australia has the full story — the link below goes straight to it.
